| |  |
| | |
| | InDex Pharmaceuticals AB |
| Profile |
InDex Pharmaceuticals is engaged in the discovery and development of so called DIMS drugs (DIMS: DNA-based Immunomodulatory Sequence) for unmet medical needs in a variety of treatment areas such as inflammation and cancer. The company’s corporate mission is to break new ground in innovative immunotherapy and thus become a preferred research and development partner to large industry players in the biopharmaceutical area.
|
| CEO | Svante Rasmuson |
| Region | |
| Webpage | http://www.indexpharmab.com/ |
| E-mail address | info@indexpharmab.com |
| Contact | Tel: +46 8 50 88 47 30
Fax: +46 8 50 88 47 39
Scheeles väg 1
171 77 Stockholm
Sweden
|